Clinical efficacy and safety of new compound single tablet antiviral drugs in the treatment of HIV/AIDS

Genvoya, Biktarvy and Dovato are recommended for the treatment of HIV/AIDS and have a good safety profile.

Authors

Institutions

Publication Details

Journal
Life Sciences
Published
2024-10-18
DOI
https://doi.org/10.1016/j.lfs.2024.123117
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical efficacy and safety of new compound single tablet antiviral drugs in the treatment of HIV/AIDS

Yunyun Yi, Xin Li, Na Zhu, Xinyu Cui et al.
Life Sciences
HIV/AIDS drug development and treatment
article

Clinical efficacy and safety of new compound single tablet antiviral drugs in the treatment of HIV/AIDS

Yunyun Yi, Xin Li, Na Zhu, Xinyu Cui, Yingying Lin
article en

Abstract

Genvoya, Biktarvy and Dovato are recommended for the treatment of HIV/AIDS and have a good safety profile.

Life SciencesVol. 358
Capital Medical University (CN), Peking University (CN), Beijing Hospital of Traditional Chinese Medicine (CN), Beijing Ditan Hospital (CN)
Good health and well-being
Openalex Percentile: Top 77%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.